Results of initial clinical trials of brain tumor chemotherapy
after osmotic blood-brain barrier disruption are promising. In general, the procedure is well tolerated. When a brain scan was to be used to document barrier modification, the radionuclide was given by intravenous bolus 2 mm after mannitol. Five mm after the mannitol infusion, methotrexate was administered into the internal carotid artery over 1 5 mm using the Medrad Mark IV arterial injector. The exact chemotherapy regimen has been described elsewhere [9] . 
Case 12
A 1 2-year-old boy had an operative resection in 1 978 for a medulloblastoma in the posterior fossa. This was followed by radiotherapy.
He had an excellent response and was well until the spring Glioblastoma: 
